Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
14:04
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

13th International Conference on Malignant Lymphoma

 

17-20 June 2015 Lugano
FAQs
   
Discussion forum - 13th International Conference on Malignant Lymphoma
    Topic - T-cell lymphoma

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
Alisertib Exhibits Broad Activity And Selectively Synergizes With Romidepsin In Preclinical Models Of T-Cell Lymphoma  Kelly Zullo 1      6/8/2015 10:43:00 PM  
A clinicopathological study of Lennert lymphoma and possible prognostic factors  Daisuke Kurita 1      6/8/2015 7:55:00 PM  
Clinical Outcome of P-Gemox for Newly Diagnosed Stage III/IV or Relapsed/Refractory ENKTL  HuiQiang Huang 1      6/8/2015 4:50:00 PM  
Immunophenotypic heterogeneity of T-LGLL: clinical and biological implications  Renato Zambello 1      6/8/2015 9:31:00 AM  
Molecular Heterogeneity of ALK-negative Anaplastic Large Cell Lymphoma  Andrew Feldman 1      6/8/2015 1:20:00 AM  
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA IN THAILAND: CLINICAL OUTCOMES, TREATMENTS, AND PROGNOSTIC FACTORS  Udomsak Bunworasate 1      6/7/2015 4:38:00 PM  
Bendamustine treatment in refractory/relapsed T cell lymphomas: a retrospective multicenter study  Emilie Reboursiere 1      6/7/2015 3:16:00 PM  
The mTORC1 Inhibitor Everolimus Produces Tumor Responses in Patients with Relapsed T-cell Non-Hodgkin Lymphoma  Thomas Witzig 1      6/6/2015 12:43:00 AM  
Targeting the MUC1-C oncoprotein is associated with downregulation of TIGAR and ROS-mediated cutaneous T-cell lymphoma cell death  Salvia Jain 1      6/3/2015 11:24:00 PM  
Characteristics and Patterns of Care of Patients (pts) =70 years with T-cell non-Hodgkin Lymphoma (TCL) in the United States (US)  Chadi Nabhan 1      6/1/2015 5:32:00 PM  
Polyethylene glycol conjugated asparaginase-CHOP in adult newly diagnosed extranodal NK/T-cell lymphoma: a multi-center prospective phase II study  Wen Zheng 1      6/1/2015 3:55:00 PM  
Phase II study of SMILE chemotherapy for relapsed/refractory peripheral T-cell lymphoma  Ritsuro Suzuki 1      6/1/2015 3:41:00 AM  
Breast Implant Associated Anaplastic Large cell Lymphoma: a new distinct clinicopathologic entity.  Camille Laurent 1      5/28/2015 3:07:00 PM  
A large prospective multicenter study of peripheral T-cell lymphoma in Thailand: clinical, histopathology, treatment outcomes, and survival  Jakrawadee Julamanee 1      5/22/2015 1:02:00 PM  
       




Most viewed poster for this congress
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center

Poster most viewed in this topic
Poster: 231
Visits: 186
Title: Clinical Characteristics and Patterns of Care of Patients (pts) with Peripheral T-cell Lymphoma (PTCLs) according to age at time of diagnosis: A T-Cell Project snapshot.
Authors: Monica Bellei , Marcheselli, Pesce, Horwitz, Vose, Montoto, Pileri, Ko, Zucca, Foss, Connors, Polliack, Zinzani, Advani, Cabrera, De Souza, Kim, Martinez, Merli, Moskowitz, Nagler, Radford, Shustov, Spina, Federico
Centre: T-Cell Project Network


 




PosterSessionOnline
Logo Draft
 
Logo Cert